Amoéba Secures New Emergency Authorization for AXPERA in French Vineyards

On April 28, 2026, Amoéba, a greentech company in Chassieu, France, announced a new 120-day emergency authorization for AXPERA. This biocontrol product targets downy mildew on grapevines in France. The authorization underscores the strong demand from the wine industry for AXPERA, as it awaits permanent approval.

This authorization, approved by the French Ministry of Agriculture, allows the use of AXPERA from May to August 2026. Supported by the French Institute of Vine and Wine, it addresses the phytosanitary emergency due to copper restrictions, resistance to conventional products, and increased disease pressure affecting up to 90% of vines in 2023.

AXPERA has shown effectiveness through trials, offering an innovative solution to manage resistance and comply with copper use regulations. This step aligns with pending permanent authorization expected soon from both French and European authorities.